Eric K. Rowinsky

Development Services Group (United States)

Also affiliated with CTI BioPharma (Italy), Neoleukin Therapeutics (United States), DE Technologies (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study”.

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00079-2

N/A

1.3DataRank · unranked

67 citations

Eric K. Rowinsky, Brandon G. Smaglo, Wasif M. Abidi, Mohamed O. Othman, Kalpesh Patel +15 more